Based on current study guidelines, ideal candidates for this class of medication typically include: Individuals with Obesity or Overweight: Those who have a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 or higher with weight-related health conditions
You might forget to eat lunch
Of the two incretin hormones, glucagon-like peptide-1 (GLP-1) has therapeutic potential to reduce body weight and plasma glucose levels
From stomach paralysis to vision loss
Keep a symptom diary noting headache frequency, duration, severity (110 scale), and any triggers like caffeine, sleep disruption, or stressthis information helps PlexusDx clinicians optimize your treatment plan
Backed by preclinical and clinical studies with human relevance